Although there are differences between the classification subtypes determined by each study, central to these classifications is the basal (expressed markers: CK5/6, CK14, CD44) BC type and the luminal (expressed markers: uroplakin, CK20, GATA3) BC type.20, 21, 23. This evidence concerns the gene CD44 and breast cancer.